SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2021$71,000
+20.3%
21,394
-3.2%
0.00%0.0%
Q2 2021$59,000
-34.4%
22,094
-47.2%
0.00%
-50.0%
Q1 2021$90,000
+30.4%
41,877
+49.7%
0.00%
+100.0%
Q4 2020$69,00027,9770.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q4 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,349,953$8,046,0002.52%
Novo Holdings A/S 2,181,843$13,004,0002.23%
Sofinnova Investments, Inc. 1,180,178$7,034,0000.64%
TPG Group Holdings (SBS) Advisors, Inc. 2,041,496$12,168,0000.09%
Eventide Asset Management 392,513$2,288,0000.08%
Blackstone Inc. 1,623,405$9,675,0000.06%
Granahan Investment Management 141,012$840,0000.05%
Janney Montgomery Scott LLC 46,861$279,0000.00%
BANK OF MONTREAL /CAN/ 5,921$35,0000.00%
BlackRock Inc. 15,755$94,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders